Retrotope, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.retrotope.com
Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY
- First Posted Date
- 2021-06-24
- Last Posted Date
- 2021-06-25
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04937530
- Locations
- 🇩🇪
Agaharied Teaching Hospital, University of Munich, Munich, MD, Germany
A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
- First Posted Date
- 2019-09-25
- Last Posted Date
- 2022-05-27
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT04102501
- Locations
- 🇺🇸
Collaborative Neuroscience Network, LLC, Long Beach, California, United States
🇺🇸UCLA, Los Angeles, California, United States
🇺🇸University of Florida, Gainesville, Florida, United States
A Natural History Study of Infantile Neuroaxonal Dystrophy
- Conditions
- Neuroaxonal Dystrophy, Infantile
- First Posted Date
- 2019-07-22
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT04027816
- Locations
- 🇨🇳
Peking University First Hospital, Beijing, China
🇪🇬National Research Centre, Cairo, Egypt
🇮🇳EN1 Neuro Services Pvt. Ltd, Mumbai, India
Natural History of Infantile Neuroaxonal Dystrophy
- Conditions
- INADInfantile Neuroaxonal Dystrophy
- First Posted Date
- 2019-06-27
- Last Posted Date
- 2020-06-29
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT03999814
- Locations
- 🇺🇸
Sarah Endemann, Los Altos, California, United States
A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- Retrotope, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT03570931
- Locations
- 🇺🇸
University of California San Francisco, Benioff Children's Hospital, San Francisco, California, United States
🇺🇸Jacobs Levy Genomics and Research Program, Morristown, New Jersey, United States
- Prev
- 1
- 2
- Next